The Community Forum - Cell & Gene Therapy, an event hosted by BioKansas in partnership with IPS, will explore novel new approaches and trends in cell and gene therapy and how growing Kansas City’s bioscience industry will positively impact the regional economy.
Biologically based drugs and therapeutics now dominate healthcare product growth and its upward trajectory is expected to be rapid and sustained due to the growing understanding of the essential application of cell and gene therapies in the advent of personalized medicine. As the bioscience industry continues to grow, it will become even more nuanced and in-demand as we develop additional cell and gene therapies. Because of this, it will become essential to continue applying the most recent biological and technical advancements to support thriving and competitive bioscience companies.
Join our virtual community forum to
- Ask direct questions and connect with industry leaders
- Learn of the latest advancements in cell and gene therapies
- Discover how advancements are altering the industry
- Explore how Kansas companies are advancing and applying cell and gene technologies and products.
"A concerted investment in cell and gene technology is vital for the Kansas City region, as it is quickly becoming one of the most dominant sectors of the pharmaceutical industry,” states Komal Hatti, IPS Director, Process Architect, program coordinator, and moderator.
10:00 - 10:05 CDT
Sonia M. Hall, Ph.D.
President & CEO at BioKansas
Cell & Gene: Technology & Medicine
10:05 - 10:20 CDT
Tom Piombino, PE
Vice President, Design at IPS-Integrated Project Services, LLC
Impact of Cell and Gene Advancement on the Pharma Industry
10:20 - 10:35 CDT
George B and Joy Rathmann Professor in Bioprocessing and Director, Amgen Bioprocessing Center
Cell & Gene in the KC Region
10:35 - 10:50 CDT
Todd Bradley, Ph.D.
Director of Immunogenomics at Genome Medicine Center and Children’s Mercy Research Institute
Cell & Gene as an Economic Driver
10:50 - 11:25 CDT
Moderated by: Jason Collins, Director of Process Architecture at IPS-Integrated Project Services, LLC
Panelists: Karthik Ramachandran, Ph.D., Chief Operating Officer and Co-Founder at Likarda; Kimberly Young, President at KC Animal Health Corridor; Trent Armbrust, Director of Strategy, Bioscience and Technology - Kansas Department of Commerce; & Heather Decker, Chief Technology Officer at Ronawk LLC
Upcoming Pharma Event Preview
11:25 - 11:28 CDT
11:28 - 11:30 CDT
Komal Hatti, NCARB, MBA, LEED AP
Director, Process Architect, Associate at IPS-Integrated Project Services, LLC